Press statements
-
Support for schools from NICE guidance
16/06/2008
-
NICE responds to Court of Appeal's ruling on Alzheimer's appraisal
01/05/2008
-
NICE welcomes new topic referral
14/04/2008
-
NICE welcomes new topic referral
12/02/2008
-
Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis - appeal decision
12/06/2007
-
NICE respond to ´flawed and inaccurate´ drug industry sponsored report on cancer drugs
21/05/2007
-
NICE appraisal of bortezomib for the treatment of relapsed and refractory multiple myeloma
20/10/2006
-
NICE issues new draft guidance on primary and secondary prevention of osteoporosis
03/10/2006
-
Update on the development of the obesity guidance
06/03/2006
-
NICE draft report on Social Value Judgements
28/11/2005
-
NICE response to Audit Commission report - managing the financial implications of NICE Guidance
08/09/2005
-
NICE appraisal of capecitabine (Xeloda) for the treatment of colorectal cancer (adjuvant)
12/08/2005
-
NICE welcomes referral of trastuzumab (Herceptin) for treatment of early stage breast cancer
21/07/2005
-
Update on Alzheimer´s appraisal
19/07/2005
-
NICE consults on the factors it should consider when developing its guidance (for example age and lifestyle)
06/05/2005
-
Publication of NICE guidance
12/04/2005
-
NICE asked to develop first guidance on public health topics, alongside additional clinical guidelines and technology appraisals
05/04/2005
-
NICE appraisal of Alzheimer´s drugs
15/03/2005
-
NICE Sponsors HSJ Awards
05/07/2004
-
NICE will not issue guidance during May 2004
21/05/2004
-
Press statement: Review of NICE Technology Appraisal Guidance No.s 28, 45 and 55 - Topotecan, PLDH and paclitaxel for ovarian cancer
20/11/2003
-
Clinical guideline on dental recall
06/04/2004
